Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Peplinski RM, Riordan JD, Schillo JL, Hannan EC, et al. Co-targeting the PI3K-Akt pathway improves response to MEK inhibition in low-grade serous ovarian cancer cell lines. Gynecol Oncol 2025;204:194-201.
PMID: 41351945


Privacy Policy